CommentDo we need more psoriasis therapies?
References (13)
- et al.
The benefit/risk profile of TNF-blocking agents: findings of a consensus panel
Semin Arthritis Rheum
(2005) - et al.
Variation in dermatologist beliefs about the safety and effectiveness of treatments for moderate to severe psoriasis
J Am Acad Dermatol
(2013) - et al.
National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening
J Am Acad Dermatol
(2008) - et al.
Pancytopenia secondary to methotrexate therapy in rheumatoid arthritis
Arthritis Rheum
(1996) - et al.
Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials
JAMA
(2006) - et al.
Long-term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate-to-severe psoriasis: results from the PHOENIX 2 study through 5 years of follow-up
Br J Dermatol
(2015)
There are more references available in the full text version of this article.
Cited by (2)
Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials
2018, The LancetCitation Excerpt :Patients with psoriasis are at increased risk of developing several comorbidities, including cardiovascular disease, depression, metabolic syndrome, joint and entheseal disease, and inflammatory bowel disease.7,8 Although the introduction of biologics has improved treatment outcomes, an unmet need remains for therapies that provide predictable and durable skin clearance with convenient dosing, thereby improving patients' quality of life.9–12 Interleukin-23, a key regulator of multiple effector cytokines, has a pivotal role in the pathogenesis of psoriasis.13–16
Acupoint injections of Autologous blood given to a patient who had psoriasis for 20 years made complete disappearance of psoriasis skin plaques in 6 months: A case report and underlining hypothesis
2017, Acupuncture and Electro-Therapeutics Research
Copyright © 2015 Elsevier Ltd. All rights reserved.